GRAL
GRAIL Inc.
$93.55
+$7.90(+9.22%)
75
Overall
60
Value
91
Tech
--
Quality
Market Cap
$2.97B
Volume
1.99M
52W Range
$16.10 - $103.00
Target Price
$74.33
Company Overview
| Mkt Cap | $2.97B | Price | $93.55 |
| Volume | 1.99M | Change | +9.22% |
| P/E Ratio | -1.5 | Open | $86.15 |
| Revenue | $125.6M | Prev Close | $85.65 |
| Net Income | $-2.0B | 52W Range | $16.10 - $103.00 |
| Div Yield | N/A | Target | $74.33 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 91 |
No chart data available
About GRAIL Inc.
GRAIL, Inc., a commercial-stage healthcare company, focuses on developing technologies for early cancer detection in the United States and internationally. It provides Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company offers development services including support for ongoing clinical studies, pilot testing, research, and therapy development. It also develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Latest News
Grail Inc. Navigates Global Trade Challenges Amid Tariffs and Regulatory Hurdles
TipRanks Auto-Generated Newsdesk•8 days ago
GRAIL Inc Announces $300M Equity Distribution Agreement
TipRanks Auto-Generated Newsdesk•10 days ago
Analysts Are Bullish on Top NA Stocks: GRAIL Inc (GRAL), Sound Point Meridian Capital, Inc. (SPMC)
Brian Anderson•10 days ago
GRAIL Inc (GRAL) Gets a Buy from Canaccord Genuity
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRAL | $93.55 | +9.2% | 1.99M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |